Showing 1 - 4 results of 4 for search '"Epidermal growth factor receptor (EGFR)"', query time: 0.04s Refine Results
  1. 1
    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer

    Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer by Ji Eun Shin, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Byoung Yong Shim

    Published 2025-02-01
    Subjects: “…Epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC)…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells

    EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells by Bita Jafary, Mostafa Akbarzadeh-Khiavi, Hamed Farzi-Khajeh, Azam Safary, Khosro Adibkia

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Emerging targeted therapies in oral oncology: Focus on EGFR inhibition

    Emerging targeted therapies in oral oncology: Focus on EGFR inhibition by Vishnu Priya Veeraraghavan, Shikhar Daniel, Arun Kumar Dasari, Kaladhar Reddy Aileni, Chaitra patil, Santosh R. Patil

    Published 2024-09-01
    Subjects: “…Epidermal growth factor receptor (EGFR)…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Mogroside ⅡE, an in vivo metabolite of sweet agent, alleviates acute lung injury via Pla2g2a-EGFR inhibition

    Mogroside ⅡE, an in vivo metabolite of sweet agent, alleviates acute lung injury via Pla2g2a-EGFR inhibition by Weichao Lü, Guoqing Ren, Kuniyoshi Shimizu, Renshi Li, Chaofeng Zhang

    Published 2024-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: